Posts
Can A Brain Tumor Become Helped By The ICT-107 Vaccine
Brain tumor awareness is home to a number of different therapies, which goes without saying. It seems as though these particular growths are going to be targeted in the best of ways, specialists being able to assess what can be done in order to help them. This is where the ICT-107 can come into play and it was one that was spoken about in a recent report. From what I have picked up on, it is the kind of report that is more than worth talking about.
An article on Medical News Today went into detail about this particular matter and I do not think that it is hard to see why. Keep in mind that glioblastoma multiforme is the condition being targeted here, which is something that can be said about most other procedures related to brain tumor awareness. The level of aggression seen in this particular condition is something that no other tumor type can match. As a result, organizations along the lines of Voices against Brain Cancer are going to focus on it.
When it comes to the cells that are involved in this particular condition, regeneration seems to come about rather quickly. This is due, at least to some degree, to the blood stream that seems to be rather constant within the body. This is a point that the American Brain Tumor Association went into detail about. In addition, it was said that the risk of the condition increases with age - especially with men - but it seems like it can come about in anyone, regardless of factors like age or gender.
A study that was done by the Cedars-Sinai Medical Group was one that was able to put the ICT-107 vaccine to use. This would be able to benefit the immune system, as it would direct attention to the cancerous cells within the body. After this was done, a tumor-killing response would follow. Keep in mind that this vaccine is administered only after the typical conditions are met, invasive surgery, chemo, and radiation included. After the vaccine was brought into play three times week at two-week intervals, results would be had.
I think that these particular results were quite positive, as it seems like seven of the sixteen patients that were originally involved could be helped that much more in the long term. Survival rates extended between 60.7 and 82.7 months, which is great for those who consistently bring attention to the matter. In addition, take into account that six of the original patients were said to be "progression-free." They did not have to worry about tumors coming back and the fact that treatment did not have to be followed up on speaks greater volumes.
An article on Medical News Today went into detail about this particular matter and I do not think that it is hard to see why. Keep in mind that glioblastoma multiforme is the condition being targeted here, which is something that can be said about most other procedures related to brain tumor awareness. The level of aggression seen in this particular condition is something that no other tumor type can match. As a result, organizations along the lines of Voices against Brain Cancer are going to focus on it.
When it comes to the cells that are involved in this particular condition, regeneration seems to come about rather quickly. This is due, at least to some degree, to the blood stream that seems to be rather constant within the body. This is a point that the American Brain Tumor Association went into detail about. In addition, it was said that the risk of the condition increases with age - especially with men - but it seems like it can come about in anyone, regardless of factors like age or gender.
A study that was done by the Cedars-Sinai Medical Group was one that was able to put the ICT-107 vaccine to use. This would be able to benefit the immune system, as it would direct attention to the cancerous cells within the body. After this was done, a tumor-killing response would follow. Keep in mind that this vaccine is administered only after the typical conditions are met, invasive surgery, chemo, and radiation included. After the vaccine was brought into play three times week at two-week intervals, results would be had.
I think that these particular results were quite positive, as it seems like seven of the sixteen patients that were originally involved could be helped that much more in the long term. Survival rates extended between 60.7 and 82.7 months, which is great for those who consistently bring attention to the matter. In addition, take into account that six of the original patients were said to be "progression-free." They did not have to worry about tumors coming back and the fact that treatment did not have to be followed up on speaks greater volumes.
About the Author:
Contact Voices Against Brain Cancer if you are searching for some additional information about brain tumor research and awareness.
0 comments:
Post a Comment